Rogel Cancer Center: University of Michigan
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer
- First Posted Date
- 2005-08-24
- Last Posted Date
- 2015-01-19
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00134355
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
- Conditions
- Multiple Myeloma
- First Posted Date
- 2005-07-01
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT00116961
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
- First Posted Date
- 2005-06-24
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT00115739
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
- Conditions
- Esophageal Cancer
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2012-12-19
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 152
- Registration Number
- NCT00003076
- Locations
- 🇺🇸
Tulane University School of Medicine, New Orleans, Louisiana, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
- Conditions
- Myelodysplastic Syndromes
- First Posted Date
- 2003-12-16
- Last Posted Date
- 2012-12-21
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Registration Number
- NCT00005598
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia
- Conditions
- Cervical CancerPrecancerous/Nonmalignant Condition
- First Posted Date
- 2003-12-05
- Last Posted Date
- 2010-09-22
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 180
- Registration Number
- NCT00003598
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
- Conditions
- Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Other: placebo
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 180
- Registration Number
- NCT00064272
- Locations
- 🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
🇺🇸University of Michigan Cancer Center CCOP Research Base, Ann Arbor, Michigan, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Curcumin for the Prevention of Colon Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-12-21
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Registration Number
- NCT00027495
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States